Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer

被引：0
|
作者：
Sun, W. [1 ]
Ma, K. [1 ]
Wang, X. [1 ]
Liu, Y. [1 ]
He, H. [1 ]
Guo, Y. [1 ]
机构：
[1] Jinlin Univ, Hosp 1, Changchun, Jilin, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Programmed death-ligand 1; neo-adjuvant chemotherapy; lung cancer;
D O I：
10.1016/j.jtho.2017.09.303
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-006
引用
收藏
页码：S1996 / S1996
页数：1
相关论文
共 50 条
  • [31] Targeting Programmed Cell Death-1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
    Constantinidou, Anastasia
    Alifieris, Constantinos
    Trafalis, Dimitrios T.
    PHARMACOLOGY & THERAPEUTICS, 2019, 194 : 84 - 106
  • [32] Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol
    Wu, Lukanxuan
    Lv, Chunzi
    Su, Yifeng
    Li, Chunyan
    Zhang, Hui
    Zhao, Xinbo
    Li, Mingjiang
    GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (03) : 251 - 256
  • [33] Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response
    Agina, Hala A.
    Ehsan, Nermine A.
    Abd-Elaziz, Taghreed A.
    Abd-Elfatah, Ghada A.
    Said, Eman M.
    Sira, Mostafa M.
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 5 (03) : 256 - 264
  • [34] Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes
    Panjwani, Poonam K.
    Charu, Vivek
    DeLisser, Monique
    Molina-Kirsch, Hernan
    Natkunam, Yasodha
    Zhao, Shuchun
    HUMAN PATHOLOGY, 2018, 71 : 91 - 99
  • [35] Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors
    Pinto, Navin
    Park, Julie R.
    Murphy, Erin
    Yearley, Jennifer
    McClanahan, Terri
    Annamalai, Lakshmanan
    Hawkins, Douglas S.
    Rudzinski, Erin R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [36] Expression of PD-L1, PD-L2 and PD-1 in thymic epithelial tumours (TETs).
    Gennatas, Spyridon
    Fernandez, Angeles Montero
    Bowman, Alex
    Ronquillo, John
    Nicholson, Andrew G.
    Popat, Sanjay
    Bowcock, Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Programmed Death-1 (PD-1) and Its Ligand PD-L1 Expression in Gastric Intraepithelial Neoplasia and Early-Stage Gastric Cancer (EGC)
    Shen, Bo
    Qian, Aihua
    Sun, Yunwei
    DIGESTION, 2020, 101 (01) : 90 - 91
  • [38] Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) distribution in triple negative breast cancer (TNBC)
    Baker, T. M.
    Gatalica, Z.
    Goldstein, L. J.
    Obeid, E.
    CANCER RESEARCH, 2017, 77
  • [39] Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
    Zak, Krzysztof M.
    Grudnik, Przemyslaw
    Magiera, Katarzyna
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    STRUCTURE, 2017, 25 (08) : 1163 - 1174
  • [40] Expression of PD-1, PD-L1, and PD-L2 in the liver in autoirnmune liver diseases
    Mataki, Norikazu
    Kikuchi, Kentaro
    Kawai, Toshihiro
    Higashiyama, Masaaki
    Okada, Yoshikiyo
    Kurihara, Chle
    Hokari, Ryota
    Kawaguchi, Atsushi
    Nagao, Shigeaki
    Kondo, Toshiro
    Itoh, Kazuro
    Miyakawa, Hiroshi
    Miura, Soichiro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (02): : 302 - 312
12345